State Of Alaska, Department Of Revenue Tg Therapeutics, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.35 Billion
- Q2 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 80,783 shares of TGTX stock, worth $2.95 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
80,783
Previous 73,956
9.23%
Holding current value
$2.95 Million
Previous $2.92 Million
0.34%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding TGTX
# of Institutions
412Shares Held
87.9MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$570 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$416 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$272 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$120 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$104 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.31B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...